Chapters

Transcript

Video

Updated Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Clinical Trials

Sara Tolaney, MD, MPH discusses updated standardized definitions for efficacy endpoints in adjuvant breast cancer clinical trials: STEEP Version 2.0.


Published

August 11, 2021

Created by

Dana-Farber

Related Presenters

Sara M. Tolaney, MD, MPH

Sara M. Tolaney, MD, MPH

Medical Oncology

Dr. Tolaney received her undergraduate degree from Princeton University in 1998 and her medical degree from UC San Francisco in 2002. She subsequently completed her residency in Internal Medicine at Johns Hopkins University, and fellowships ...

View Full Profile